Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rendani T. Mafuyeka"'
Publikováno v:
Southern African Journal of Infectious Diseases, Vol 39, Iss 1, Pp e1-e7 (2024)
Background: Laboratory-based molecular assays return cycle threshold (Ct) values for each gene target. There is limited hyperlocal information describing the Ct, age and sex trends during the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
Externí odkaz:
https://doaj.org/article/4cd3d051d68b4321ac76df41f75f61f6
Publikováno v:
Southern African Journal of HIV Medicine, Vol 22, Iss 1, Pp e1-e7 (2021)
Background: The human immunodeficiency virus type-2 (HIV-2) prevalence in South Africa (SA) is unknown, however, sporadic cases have been reported. Human immunodeficiency virus -1 and 2 differentiation is not part of most South African public laborat
Externí odkaz:
https://doaj.org/article/6f78cd5f2a1646ab9a399f80ac08e4f1
Autor:
Simnikiwe H Mayaphi, Marieke Brauer, Daniel M Morobadi, Ahmad H Mazanderani, Rendani T Mafuyeka, Steve A S Olorunju, Gregory R Tintinger, Anton Stoltz
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e93702 (2014)
BACKGROUND: Cytomegalovirus (CMV) infection is associated with severe diseases in immunosuppressed patients; however, there is a lack of data for pre-emptive therapy in patients with HIV/AIDS. METHOD: This was a retrospective study, which enrolled pa
Externí odkaz:
https://doaj.org/article/021132b607be432d88e836e716b6beed
Publikováno v:
Southern African Journal of HIV Medicine, Volume: 22, Issue: 1, Pages: 1-7, Published: 2021
Southern African Journal of HIV Medicine; Vol. 22 No. 1 (2021)
Southern African Journal of HIV Medicine, Vol 22, Iss 1, Pp e1-e7 (2021)
Southern African Journal of HIV Medicine
Southern African Journal of HIV Medicine; Vol. 22 No. 1 (2021)
Southern African Journal of HIV Medicine, Vol 22, Iss 1, Pp e1-e7 (2021)
Southern African Journal of HIV Medicine
Background:The human immunodeficiency virus type-2 (HIV-2) prevalence in South Africa (SA) is unknown, however, sporadic cases have been reported. Human immunodeficiency virus -1 and 2 differentiation is not part of most South African public laborato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3505d6f7dbdfd5efd2e642554fc1d1c9
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S2078-67512021000100009&lng=en&tlng=en
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S2078-67512021000100009&lng=en&tlng=en
Autor:
Steve A.S. Olorunju, Anton Stoltz, Gregory Ronald Tintinger, Ahmad Haeri Mazanderani, Daniel M. Morobadi, Rendani T. Mafuyeka, Simnikiwe H. Mayaphi, Marieke Brauer
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 4, p e93702 (2014)
PLoS ONE, Vol 9, Iss 4, p e93702 (2014)
BACKGROUND: Cytomegalovirus (CMV) infection is associated with severe diseases in immunosuppressed patients; however, there is a lack of data for pre-emptive therapy in patients with HIV/AIDS. METHOD: This was a retrospective study, which enrolled pa